Antifungal Potential of Secondary Metabolites Derived from Arcangelisia flava (L.) Merr.: An Analysis of In Silico Enzymatic Inhibition and In Vitro Efficacy against Candida Species

• Published in: Molecules (Basel, Switzerland) Switzerland), 2024-05, Vol.29 (10), p.2373
• Main Authors: Hendra, Rudi, Agustha, Aulia, Frimayanti, Neni, Abdulah, Rizky, Teruna, Hilwan Yuda
• Format: Article
• Language: English
• Subjects: antifungal activity; Antifungal agents; Antifungal Agents - chemistry; Antifungal Agents - pharmacology; Apocynaceae - chemistry; Arcangelisia flava; bioassay-guided fractionation; Bioassays; Biosynthesis; Candida - drug effects; Candida species; Chromatography; Computer Simulation; Drug resistance; Enzymes; Fractionation; Fungal infections; Hepatitis; Ligands; Metabolites; Microbial Sensitivity Tests; molecular docking; Molecular Docking Simulation; Pathogens; pharmacophore modeling; Plant Extracts - chemistry; Plant Extracts - pharmacology; R&D; Research & development; Secondary Metabolism
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules29102373

Considering the escalating resistance to conventional antifungal medications, it is critical to identify novel compounds that can efficiently counteract this challenge. The purpose of this research was to elucidate the fungicidal properties of secondary metabolites derived from , with a specific focus on their efficacy against species. This study utilized a combination approach comprising laboratory simulations and experiments to discern and evaluate the biologically active constituents present in the dichloromethane extract of . The in vitro experiments demonstrated that compounds (palmatine) and (fibraurin) exhibited antifungal properties. The compounds exhibited minimum inhibitory concentrations (MICs) ranging from 15.62 to 62.5 µg/mL against sp. Moreover, compound demonstrated a minimum fungicidal concentration (MFC) of 62.5 µg/mL against and . In contrast, compound exhibited an MFC of 125 µg/mL against both species. Based on a molecular docking study, it was shown that compounds and have a binding free energy of -6.6377 and -6.7075 kcal/mol, respectively, which indicates a strong affinity and specificity for fungal enzymatic targets. This study utilized pharmacophore modeling and Density Functional Theory (DFT) simulations to better understand the interaction dynamics and structural properties crucial for antifungal activity. The findings underscore the potential of secondary metabolites derived from to act as a foundation for creating novel and highly efficient antifungal treatments, specifically targeting fungal diseases resistant to existing treatment methods. Thus, the results regarding these compounds can provide references for the next stage in antifungal drug design. Further investigation is necessary to thoroughly evaluate these natural substances' clinical feasibility and safety characteristics, which show great potential as antifungal agents.